Telomir Pharmaceuticals (TELO) Earnings Date & Reports

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TELO is expected to report earnings to rise 33.33% to -3 cents per share on September 02

Telomir Pharmaceuticals TELO Stock Earnings Reports

Q2'26

Est.

$-0.04

Q1'26

Est.

$-0.03

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.03

The last earnings report on May 14 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 20.15K shares outstanding, the current market capitalization sits at 89.41M.

View a ticker or compare two or three

Compare

TELO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TELO